Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection.
Riggs
M W
MW
Department of Veterinary Science and Microbiology, University ofArizona, Tucson, USA. mriggs@u.arizona.edu
Schaefer
D A
DA
Kapil
S J
SJ
Barley-Maloney
L
L
Perryman
L E
LE
McNeil
M R
MR
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000913:Antibodies, Protozoan / Q000276:immunology / Q000627:therapeutic use*; D003457:Cryptosporidiosis / Q000469:parasitology / Q000628:therapy*; D016785:Cryptosporidium parvum / Q000276:immunology* / Q000378:metabolism; D005260:Female; D007116:Immunization, Passive; D008024:Ligands; D008562:Membrane Glycoproteins; D051379:Mice; D011956:Receptors, Cell Surface / Q000276:immunology* / Q000378:metabolism; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; C423451:CSL receptor, human; D008024:Ligands; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface